Eculizumab in Adult Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH) in China

Trial Identifier: D7414C00001
Sponsor: Alexion Pharmaceuticals, Inc.
Collaborator:
Astrazeneca
NCTID:: NCT05886244
Start Date: July 2023
Primary Completion Date: June 2025
Study Completion Date: June 2025
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, CN-100730
CN Hangzhou, CN, 310003
CN Nantong, CN, 226001
CN Shanghai, CN, 200040
CN Tianjian, CN, 300020
CN Tianjin, CN, 300052
CN Wuhan, CN, 430022